ArticleBritish journal of pharmacology2017

Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.

Declan McLaughlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.